Drawing for VASCUPLANT

USPTO serial 79001685

VASCUPLANT

Reviewed by CopyMark Law Group

Reg. 3018043Status 404
Filing date
Status date
Registration date
Nov 22, 2005
Examiner
FRENCH, CURTIS W
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VASCUPLANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals and biochemicals for use in the manufacture of tissue engineering based products, somatic cell therapeutics, and cell based products for regenerative medicine; biocatalysts for use in the manufacture of industrial chemicalsSECTION 71 - CANCELLED
005Medical and veterinary preparations and substances for the treatment of skeletal diseases, diseases of the connective tissue, neurological diseases, urological diseases, dermatological diseases, liver diseases and auto-immune diseases, heart or circulation diseases; products and substances for medical and veterinary purposes produced or modified by genetic engineering, namely, cells, proteins, growth factors, cytokines, hormones, antibodies, enzymes, all for use in the treatment of coronary heart disease, atherosclerosis, vascular injuries, cartilage damage, bone damage, wound healing, regeneration of nerves and spinal cords, bladder or urethra damage, skin repair, and autoimmune liver diseases; biological materials intended for subsequent implantation, namely, endothelial cells, muscle cells, connective tissue, blood vessels, cells, organ transplants and implants, tissue transplants and implants; biochemicals for medical purposes, namely cell culture media, carriers for cell cultures, nutrient media, cytokines, hormones, signal transduction molecules, antibodies, nucleotides, ribonucleotides, primers, enzymes, proteins and growth factors; diagnostic agents for medical use; endothelial cell transplants and implants; organ transplants and implants composed of biological materials, tissue transplants and implants composed of biological materials; biological resorbent and non-resorbent substrates in combination with endothelial cell transplants; coated materials with endothelial cells and/or in combination with muscle and connective tissue cells for use in transplantation; biological resorbent and non-resorbent substances in combination with endothelial cell and vessel cell transplantsSECTION 71 - CANCELLED
010Medical and surgical apparatus and instruments, namely endoscopical devices; implants consisting of artificial materials, artificial tissue and tissue replacement for medical purposesSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2013DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jun 30, 2013DETHDEATH OF INTERNATIONAL REGISTRATION
Nov 30, 2012C71TCANCELLED SECTION 71
Oct 5, 2007FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jul 19, 2006FICSFINAL DISPOSITION NOTICE SENT TO IB
Jul 19, 2006FIMPFINAL DISPOSITION PROCESSED
Jul 12, 2006FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 22, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 30, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 10, 2005NPUBNOTICE OF PUBLICATION
May 3, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 29, 2005ALIEASSIGNED TO LIE
Apr 25, 2005CNEAEXAMINERS AMENDMENT MAILED
Apr 22, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2005CNEAEXAMINERS AMENDMENT -WRITTEN
Apr 7, 2005ACECAMENDMENT FROM APPLICANT ENTERED
Mar 14, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2005MAILPAPER RECEIVED
Mar 4, 2005FAXXFAX RECEIVED
Oct 7, 2004RFNTREFUSAL PROCESSED BY IB
Sep 8, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 10, 2004DOCKASSIGNED TO EXAMINER
Apr 27, 2004NWAPNEW APPLICATION ENTERED
Apr 21, 2004SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance